Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04676529
What this trial is testing

Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis

Who this might be right for
MyelofibrosisPrimary Myelofibrosis (PMF)Post- Essential Thrombocythemia Myelofibrosis+1 more
Syntara 43
Early research (Phase 1)Study completedNCT01658839
What this trial is testing

Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients

Who this might be right for
GlaucomaOcular Hypertension
Alcon Research 25
Early research (Phase 1)Study completedNCT01455701
What this trial is testing

Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT03455829
What this trial is testing

G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-small Cell Lung Cancer
G1 Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT03537495
What this trial is testing

Pharmacokinetic Study of Linezolid for TB Meningitis

Who this might be right for
Tuberculosis, MeningealLinezolid
Universitas Padjadjaran 36
Early research (Phase 1)Study completedNCT01809353
What this trial is testing

To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 32
Large-scale testing (Phase 3)Ended earlyNCT02245737
What this trial is testing

An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease

Who this might be right for
Alzheimer´s Disease
AstraZeneca 2,218
Testing effectiveness (Phase 2)UnknownNCT02330367
What this trial is testing

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Hangzhou ACEA Pharmaceutical Research Co., Ltd. 368
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Early research (Phase 1)Study completedNCT04670796
What this trial is testing

A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects

Who this might be right for
Healthy
Shanghai Henlius Biotech 111
Testing effectiveness (Phase 2)Study completedNCT00259038
What this trial is testing

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

Who this might be right for
Heart Failure, CongestiveHeart DecompensationLeft Ventricular Failure+2 more
Daiichi Sankyo 162
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122026
What this trial is testing

Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV

Who this might be right for
HIV SeropositivityPregnancyTuberculosis Infection
The Aurum Institute NPC 252
Early research (Phase 1)UnknownNCT05183243
What this trial is testing

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerPancreatic Cancer+2 more
Suzhou Genhouse Bio Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Early research (Phase 1)Ended earlyNCT02168725
What this trial is testing

Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors

Who this might be right for
NeoplasmsAdvanced Solid Tumor
Traws Pharma, Inc. 26
Early research (Phase 1)UnknownNCT05865574
What this trial is testing

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

Who this might be right for
Healthy Men
Bio-Thera Solutions 38
Early research (Phase 1)Not Yet RecruitingNCT07634874
What this trial is testing

Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of KH607 in Healthy Chinese Participants

Who this might be right for
Food Effect of KH607 in Chinese Health Participants
Chengdu Kanghong Pharmaceutical Group Co., Ltd. 16
Early research (Phase 1)Study completedNCT06657560
What this trial is testing

Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Contrast-Enhanced Magnetic Resonance Imaging Detection
Shanghai Shengdi Pharmaceutical Co., Ltd 41
Early research (Phase 1)Study completedNCT00816660
What this trial is testing

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Baxalta now part of Shire 32
Early research (Phase 1)Study completedNCT00047346
What this trial is testing

Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Next Page